OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts

BACKGROUND: Bladder cancer lacks useful and robust prognostic markers to stratify patients at risk. Our study is to identify a robust prognostic marker for bladder cancer. METHODS: The transcriptome and clinical data of bladder cancer were downloaded from multiple databases. We searched for genes wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jiaxing, Xu, Xiao, Li, Tianren, Yao, Jihang, Yu, Meng, Zhu, Yuyan, Sun, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634430/
https://www.ncbi.nlm.nih.gov/pubmed/34868901
http://dx.doi.org/10.3389/fonc.2021.650678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634430/
https://www.ncbi.nlm.nih.gov/pubmed/34868901
http://dx.doi.org/10.3389/fonc.2021.650678

Ejemplares similares